Avalon Pharma, Bio-Thera reach license agreements for BAT3306 in MENA
Mubasher - 2/4/2026 12:48:29 PM - GMT (+4 )
Mubasher - 2/4/2026 12:48:29 PM - GMT (+4 )
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) entered into a strategic commercialization agreement with Bio-Thera Solutions to register Pembrolizumab in Saudi Arabia and MENA markets Under the agreement, …
read more
read more


